Autologous tumor infiltrating lymphocytes ITIL-168
Term · Oncology and biomedicine · MLC-T-ONC-011793
A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's digested and cryopreserved tumor, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs ITIL-168 specifically recognize and kill the patient's tumor cells.
| Identifier | MLC-T-ONC-011793 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous TILs ITIL-168 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011793",
"term": "Autologous tumor infiltrating lymphocytes ITIL-168",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's digested and cryopreserved tumor, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs ITIL-168 specifically recognize and kill the patient's tumor cells.",
"synonyms": [
"autologous TILs ITIL-168"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-tumor-infiltrating-lymphocytes-itil-168/"
}
Record 3,131 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.